Tobacco
smoke is an important risk factor for various human
cancers, including
esophageal cancer. How
benzo [a]pyrene diol
epoxide (
BPDE), a
carcinogen present in tobacco
smoke as well as in environmental pollution, induces esophageal
carcinogenesis has yet to be defined. In this study, we investigated the molecular mechanism responsible for
BPDE-suppressed expression of
retinoic acid receptor-beta2 (RAR-beta2) in
esophageal cancer cells. We treated
esophageal cancer cells with
BPDE before performing methylation-specific polymerase chain reaction (MSP) to find that
BPDE induced methylation of the RAR-beta2 gene promoter. We then performed
chromatin immunoprecipitation (ChIP) assays to find that
BPDE recruited genes of the methylation machinery into the RAR-beta2 gene promoter. We found that
BPDE recruited
DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), but not beta (DNMT3B), in a time-dependent manner to methylate the RAR-beta2 gene promoter, which we confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis of the reduced RAR-beta2 expression in these
BPDE-treated
esophageal cancer cell lines. However,
BPDE did not significantly change DNMT3A expression, but it slightly reduced DNMT3B expression.
DNA methylase inhibitor
5-aza-2'-deoxycytidine (5-Aza) and DNMT3A
small hairpin RNA (
shRNA) vector antagonized the effects of
BPDE on RAR-beta2 expressions. Transient transfection of the DNMT3A
shRNA vector also antagonized
BPDE's effects on expression of RAR-beta2, c-Jun, phosphorylated extracellular signal-regulated
protein kinases 1/2 (ERK1/2), and
cyclooxygenase-2 (COX-2), suggesting a possible
therapeutic effect. The results of this study form the link between the
esophageal cancer risk factor
BPDE and the reduced RAR-beta2 expression.